Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NMT Medical/Integra Lifesciences

This article was originally published in The Gray Sheet

Executive Summary

NMT's divestiture of the Selector ultrasonic aspirator, Ruggles surgical instruments and cryosurgery product lines to Integra LifeSciences for $12 mil. will enable the firm to refocus on its core cardiovascular business, the firm announces March 21. The product lines generated 1999 revenues of approximately $12.1 mil. In connection with the acquisition, Integra will change the name of its neurosurgical device business from Integra NeuroCare to Integra NeuroSciences, expand its direct sales force focusing on neurotrauma and neurosurgery to 45 U.S. reps, and build sales forces in the U.K. and Ireland

You may also be interested in...



Integra Boosts Neurosurgery Business Through Arthrocare Distribution Deal

Integra Lifesciences' decision to market Arthrocare's Coblation surgical system for brain tumor removal procedures is a part of the firm's ongoing strategy to bolster its growing neurology business.

Daraprim Drug Pricing Suit Against Shkreli And Vyera May Signal Future FTC Actions

In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.

UsernamePublicRestriction

Register

MT013164

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel